CureVac NV (CVAC)
2.56
+0.07
(+2.81%)
USD |
NASDAQ |
Nov 21, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
CureVac Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0396 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | |
| March 31, 2020 | -1.536 |
| December 31, 2019 | -1.519 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.536
Minimum
Mar 2020
0.0396
Maximum
Sep 2021
-0.1675
Average
--
Median
Sep 2020
Debt to Equity Ratio Benchmarks
| BioNTech SE | 0.0127 |
| Bayer AG | 0.00 |
| Affimed NV | 0.469 |
| InflaRx NV | 0.00 |
| Immatics NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 954.04M |
| Total Liabilities (Quarterly) | 144.63M |
| Shareholders Equity (Quarterly) | 809.41M |
| Current Ratio | 6.197 |